KLF5 and hepatocellular carcinoma: KLF5 acetylation plays the opposite role in HCC growth, as deacetylated KLF5 exhibits protumor activity, and blocking transforming growth factor beta (TGF-β) signaling (Fig. 1E) attenuates the inhibitory activity of KLF5.